AbCellera Biologics Inc. Common Shares

formerly AbCelleraIPO

AbCellera

Public · Vancouver, Canada · Founded 2012 · $115.8M raised

Headquarters
Vancouver
Employees
201–500
Founded
2012
Business Model
B2B
Total Funding
$115.8M
Last Round
$105.0M Series BMay 2020
Rounds
3
Type
Public

About

AbCellera (Nasdaq: ABCL) is a Vancouver-based clinical-stage biotechnology company that uses AI-powered microfluidic technology and single-cell analysis to discover and develop antibody medicines. It has completed over 100 therapeutic discovery programs across diverse indications, and has pivoted from a partnership model to advancing its own pipeline in oncology, endocrinology, and immunology.

Summary

AbCellera Biologics Inc. Common Shares is an Artificial Intelligence company based in Vancouver, Canada, founded in 2012. It has raised $115.8M in total across 3 rounds, most recently a $105.0M Series B round in May 2020. Investors include DCVC (Data Collab) and OrbiMed.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPODec 2020
$555.5M

Sign up to see all 5 rounds

Seed through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AbCellera Biologics Inc. Common Shares on Indexed.vc
<a href="https://indexed.vc/companies/abcellera-biologics-inc-common-shares"><img src="https://indexed.vc/api/badge/company/abcellera-biologics-inc-common-shares" alt="AbCellera Biologics Inc. Common Shares on Indexed.vc" width="260" height="76" /></a>